Arteriovenous malformation in the adult mouse brain resembling the human disease

Annals of Neurology

Volumn 69, Issue 6, 2011, Pages 954-962

  Walker, Espen J ^a   Su, Hua ^a   Shen, Fanxia ^a   Choi, Eun Jung ^a   Oh, S Paul ^b   Chen, Grant ^a   Lawton, Michael T ^a   Kim, Helen ^a   Chen, Yongmei ^a   Chen, Wanqiu ^a   Young, William L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; EPHRIN RECEPTOR B4; JAGGED1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; CONTROLLED STUDY; DYSPLASIA; EXON; GENE DELETION; GENE EXPRESSION; GENE MUTATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULMONARY ARTERIOVENOUS FISTULA;

ACTIVIN RECEPTORS, TYPE II; ANIMALS; ARTERIOVENOUS MALFORMATIONS; BRAIN; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, EPHB4; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79959409317     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22348     Document Type: Article

References (45)

1. Kim H, Marchuk DA, Pawlikowska L, et al. Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations. Acta Neurochir Suppl 2008; 105: 199-206.
2. Fleetwood IG, Steinberg GK., Arteriovenous malformations. Lancet 2002; 359: 863-873. (Pubitemid 34234796)
3. Mullan S, Mojtahedi S, Johnson DL, Macdonald RL., Embryological basis of some aspects of cerebral vascular fistulas and malformations. J Neurosurg 1996; 85: 1-8. (Pubitemid 26195030)
4. Kim H, Sidney S, McCulloch CE, et al. Racial/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke 2007; 38: 2430-2437. (Pubitemid 47329618)
5. Kim H, Pawlikowska L, Young WL., Genetics and vascular biology of brain vascular malformations. In:, Mohr JP, Wolf PA, Grotta JC, et al., eds. Stroke: pathophysiology, diagnosis, and management. 5th ed. Philadelphia: Churchill Livingstone Elsevier, 2010.
6. Potter CA, Armstrong-Wells J, Fullerton HJ, et al. Neonatal giant pial arteriovenous malformation: genesis or rapid enlargement in the third trimester. J Neurointervent Surg 2009; 1: 151-153.
7. Jeffree RL, Stoodley MA., Postnatal development of arteriovenous malformations. Pediatr Neurosurg 2009; 45: 296-304.
8. Kim H, McCulloch CE, Johnston SC, et al. Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol 2010; 171: 1317-1322.
9. Du R, Hashimoto T, Tihan T, et al. Growth and regression of an arteriovenous malformation in a patient with hereditary hemorrhagic telangiectasia: case report. J Neurosurg 2007; 106: 470-477. (Pubitemid 46354302)
10. Mahajan A, Manchandia TC, Gould G, Bulsara KR., De novo arteriovenous malformations: case report and review of the literature. Neurosurg Rev 2010; 33: 115-119.
11. Takagi Y, Kikuta KI, Nozaki K, Hashimoto N., Early regrowth of juvenile cerebral arteriovenous malformations: report of 3 cases and immunohistochemical analysis. Surg Neurol 2010; 73: 100-107.
12. Hashimoto T, Mesa-Tejada R, Quick CM, et al. Evidence of increased endothelial cell turnover in brain arteriovenous malformations. Neurosurgery 2001; 49: 124-131.
13. Letteboer TG, Mager JJ, Snijder RJ, et al. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet 2006; 43: 371-377.
14. Matsubara S, Mandzia JL, ter Brugge K, et al. Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol 2000; 21: 1016-1020. (Pubitemid 30390534)
15. Mahmoud M, Allinson KR, Zhai Z, et al. Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ Res 2010; 106: 1425-1433.
16. Park SO, Wankhede M, Lee YJ, et al. Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J Clin Invest 2009; 119: 3487-3496.
17. Hao Q, Zhu Y, Su H, et al. VEGF induces more severe cerebrovascular dysplasia in Endoglin+/- than in Alk1+/- mice. Transl Stroke Res 2010; 1: 197-201.
18. Park SO, Lee YJ, Seki T, et al. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2 (HHT2). Blood 2008; 111: 633-642.
19. Shen F, Su H, Liu W, et al. Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain. Front Biosci 2006; 11: 3190-3198. (Pubitemid 43800405)
20. Su H, Lu R, Kan YW., Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc Natl Acad Sci U S A 2000; 97: 13801-13806.
21. Chu D, Sullivan CC, Weitzman MD, et al. Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors. J Thorac Cardiovasc Surg 2003; 126: 671-679. (Pubitemid 37151949)
22. Yang GY, Zhao Y, Davidson BL, Betz AL., Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury. Brain Res 1997; 751: 181-188. (Pubitemid 27132547)
23. Soriano P., Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21: 70-71. (Pubitemid 29036285)
24. Hao Q, Liu J, Pappu R, et al. Contribution of bone marrow-derived cells associated with brain angiogenesis is primarily through leucocytes and macrophages. Arterioscler Thromb Vasc Biol 2008; 28: 2151-2157.
25. Atkinson RP, Awad IA, Batjer HH, et al. Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke 2001; 32: 1430-1442.
26. Bendszus M, Meyer B., Arteriovenous malformations of the brain. Lessons to learn. Stroke 2008; 39: 741-742. (Pubitemid 351619578)
27. Zhang ZG, Zhang L, Jiang Q, et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000; 106: 829-838.
28. Bederson JB, Wiestler OD, Brustle O, et al. Intracranial venous hypertension and the effects of venous outflow obstruction in a rat model of arteriovenous fistula. Neurosurgery 1991; 29: 341-350.
29. Massoud TF, Vinters HV, Chao KH, et al. Histopathologic characteristics of a chronic arteriovenous malformation in a swine model: preliminary study. AJNR Am J Neuroradiol 2000; 21: 1268-1276. (Pubitemid 30655661)
30. Tu J, Karunanayaka A, Windsor A, Stoodley MA., Comparison of an animal model of arteriovenous malformation with human arteriovenous malformation. J Clin Neurosci 2010; 17: 96-102.
31. Murphy PA, Lam MT, Wu X, et al. Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice. Proc Natl Acad Sci U S A 2008; 105: 10901-10906.
32. Srinivasan S, Hanes MA, Dickens T, et al. A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet 2003; 12: 473-482. (Pubitemid 36305588)
33. Hao Q, Zhu Y, Yang GY, et al. Cerebrovascular dysplasia in endoglin and alk1 haploinsufficient mice after VEGF stimulation: evidence for a "response-to-injury" hypothesis for hereditary hemorrhagic telangectasia [Abstract]. Stroke 2010; 41:e11 (P39).
34. Akers AL, Johnson E, Steinberg GK, et al. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCM): evidence for a 2-hit mechanism of CCM pathogenesis. Hum Mol Genet 2009; 18: 919-930.
35. Gault J, Awad IA, Recksiek P, et al. Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery 2009; 65: 138-144.
36. Hao Q, Su H, Marchuk DA, et al. Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation. Am J Physiol Heart Circ Physiol 2008; 295: H2250-2256.
37. Maher CO, Piepgras DG, Brown RD Jr, et al. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 2001; 32: 877-882. (Pubitemid 32285153)
38. Lebrin F, Srun S, Raymond K, et al. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 2010; 16: 420-428.
39. Lob HE, Marvar PJ, Guzik TJ, et al. Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension 2010; 55: 277-283.
40. Argaw AT, Gurfein BT, Zhang Y, et al. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A 2009; 106: 1977-1982.
41. Toporsian M, Jerkic M, Zhou YQ, et al. Spontaneous adult-onset pulmonary arterial hypertension attributable to increased endothelial oxidative stress in a murine model of hereditary hemorrhagic telangiectasia. Arterioscler Thromb Vasc Biol 2010; 30: 509-517.
42. Goumans MJ, Valdimarsdottir G, Itoh S, et al. Balancing the activation state of the endothelium via two distinct TGF- beta type I receptors. EMBO J 2002; 21: 1743-1753. (Pubitemid 34614630)
43. Goumans MJ, Valdimarsdottir G, Itoh S, et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 2003; 12: 817-828. (Pubitemid 37352776)
44. Lamouille S, Mallet C, Feige JJ, Bailly S., Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 2002; 100: 4495-4501. (Pubitemid 35429690)
45. David L, Mallet C, Vailhe B, et al. Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles for JNK and ERK. J Cell Physiol 2007; 213: 484-489. (Pubitemid 47509730)